US Stock MarketDetailed Quotes

ATOS Atossa Therapeutics

Watchlist
  • 1.2200
  • +0.0300+2.52%
Close Nov 22 16:00 ET
  • 1.2137
  • -0.0063-0.52%
Post 20:02 ET
153.48MMarket Cap-5809P/E (TTM)

About Atossa Therapeutics Company

Atossa Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. The company was founded by Steven C. Quay and Shu Chih Chen in December 2008 and is headquartered in Seattle, WA.

Company Profile

SymbolATOS
Company NameAtossa Therapeutics
Listing DateNov 8, 2012
Issue Price5.00
Founded2008
CEODr. Steven C. Quay, M.D.
MarketNASDAQ
Employees12
Fiscal Year Ends12-31
Address10202 5th Avenue North East,Suite 200
CitySeattle
ProvinceWashington
CountryUnited States of America
Zip Code98125
Phone1-206-588-0256
Websitehttp://www.atossatherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Steven C. Quay, M.D.
  • Chairman of the Board, President and Chief Executive Officer
  • 2.36M
  • Heather Rees
  • Senior Vice President, Finance and Accounting and Principal Accounting Officer
  • 687.46K
  • Dr. Tessa Cigler, M.D.,M.P.H.
  • Director
  • --
  • Dr. Shu-Chih Chen, PhD
  • Director
  • 116.17K
  • Richard I. Steinhart
  • Independent Director
  • 146.17K
  • Jonathan F. Finn, C.F.A.
  • Independent Director
  • 93.98K
  • Dr. Stephen J. Galli, M.D.
  • Independent Director
  • 144.92K
  • H. Lawrence Remmel
  • Independent Director
  • 144.92K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data